OLUFUNMILAYO ADEWUMI: Open Payments
NPI 1083743819 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 13 payments from 10 companies in 2025. Trend: 2023 $44 · 2024 $149 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 1 | $212 |
| Gilead Sciences, Inc. | 1 | $127 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Celgene Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
| TerSera Therapeutics LLC | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: XYNTHA, Trodelvy, KISQALI, LYNPARZA, OPDIVO, OJJAARA, Onivyde, Zoladex.
Industry payments across OH — which companies pay providers there.
